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Background: Recent studies indicate postprandial triglyceride (TG) had a better association with cardiovascular events and 
metabolic syndrome than fasting TG. The authors of the present study investigated the metabolic and clinical relevance of post-
prandial TG. 
Methods: In a cross-sectional retrospective study, the authors of the present study compared fasting and postprandial TG and 
analyzed the relationship between postprandial TG and various demographic and metabolic parameters in 639 Korean subjects 
with type 2 diabetes (T2D, group I, n=539) and impaired fasting glucose (IFG, group II, n=100) after ingestion of a standardized 
liquid meal (total 500 kcal, 17.5 g fat, 68.5 g carbohydrate, and 17.5 g protein). 
Results: Fasting and postprandial TG were significantly correlated (r=0.973, r=0.937, P<0.001) in group I and II, respectively. 
Of the variables, total cholesterol, waist circumference and body mass index were significantly correlated with fasting and post-
prandial TG in both groups. Only postprandial TG showed a significant correlation with glucose metabolic parameters (e.g., 
postprandial glucose, homeostatic model assessment of insulin resistance [HOMA-IR], and fasting C-peptide) in subjects with 
T2D. Multiple regression analysis showed fasting TG and HOMA-IR could be predictable variables for postprandial TG in sub-
jects with T2D.
Conclusion: Postprandial TG was very strongly correlated with fasting TG. The authors of the present study suggest insulin re-
sistance may be more associated with postprandial TG than fasting TG in Korean T2D patients on a low-fat diet.
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INTRODUCTION
Well-known characteristics of diabetic dyslipidemia include 
elevated levels of fasting triglyceride (TG), decreased levels of 
high density lipoprotein cholesterol (HDL-C), and increased 
portion of small dense low density lipoprotein cholesterol 
(LDL-C) particles in LDL cholesterol [1]. Similar to the abrupt 
surge in postprandial glucose after an oral glucose tolerance 
test in type 2 (T2) diabetics, a rise in circulating TG is a com-
mon occurrence after ingestion of a high-fat meal. Although 
elevated postprandial TG is expected after consumption of a 
fat-containing meal, not all subjects present hypertriglyceride-
mia requiring TG-lowering therapy. The levels of postprandial 
or non-fasting TG are mainly influenced by not only the diet 
contents [2] but also the time of sampling for non-fasting TG 
[3]. Postprandial TG level differs according to the fat amount 
in a meal. Several studies reported a very low (5 g) or low (<15 
g) amount of dietary fat did not significantly increase post-
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prandial TG, a moderate (30 to 50 g) amount of fat increased 
postprandial TG dose dependently, and a very high (>80 g) 
amount of fat exaggeratedly increased postprandial TG with-
out dose-dependence [2,4].
 Postprandial TG has been suggested as an independent risk 
factor for cardiovascular disease (CVD) in healthy subjects [5-
7]. Several studies support the hypothesis postprandial TG is 
correlated with carotid IMT and waist circumference (WC), 
and furthermore superior to fasting TG in association with 
metabolic syndrome [8-10]. However, the potential effects of 
postprandial hypertriglyceridemia on the development of ath-
erosclerosis are still controversial in subjects with type 2 dia-
betes (T2D) [11]. In addition, the metabolic associations of 
postprandial TG in Korean patients with T2D are not well elu-
cidated, and the clinical and laboratory parameters affecting 
the levels of non-fasting TG also remain unclear. Thus, the au-
thors of the present study investigated the metabolic relation 
and clinical implications of postprandial TG after a particular 
low-fat diet in Korean T2 diabetic patients who used to have a 
balanced low-fat diet.
METHODS
Patients and research design
In a clinic-based, retrospective cross-sectional study, patients 
who satisfied specific criteria based on their medical records 
were analyzed. Inclusion criteria were patients enrolled in the 
diabetes registry of Severance Diabetes Center between July 
2009 and August 2010. The subjects were registered first-time 
visitors to the center, patients who performed a standardized 
mixed-meal stimulation test (Ensure; total 500 kcal, 17.5 g fat, 
68.5 g carbohydrate, and 17.5 g protein; Meiji Dairies Co., To-
kyo, Japan) or patients who had diabetes complication work-
up performed. In the registry protocol, blood samples were 
collected at 0 and 90 minutes (basal and stimulated level, re-
spectively) for glucose, TG, insulin, and C-peptide analyses af-
ter injection of a standardized mixed-meal stimulation test. 
Exclusion criteria included insulin users, severe liver or kidney 
disease, thyroid disorders, pregnancy, steroid therapy, heavy 
alcoholics, and hematologic as well as malignant diseases. The 
study protocol was approved by the Ethics Committee of the 
Yonsei University College of Medicine. The subjects were clas-
sified into 2 groups based on the American Diabetes Associa-
tion (ADA) 2011 guidelines: group I, subjects with T2D; group 
II, subjects with impaired fasting glucose subjects (IFG; in-
creased risk for diabetes).
 Anthropometric measurements of individuals wearing light 
clothing and no shoes were conducted. WC was measured 
with the tape measure placed horizontally at the level of the 
umbilicus while the participant gently exhaled. The body mass 
index (BMI) was calculated as weight in kilograms divided by 
a square of height in meters.
 
Laboratory measurements 
Plasma TG, total cholesterol, HDL-C, blood urea nitrogen, 
creatinine, AST, and ALT, were assayed by routine Hitachi 7600 
autoanalyzer (Hitachi Instruments Service, Tokyo, Japan). 
LDL-C was calculated using the Friedewald equation. Plasma 
glucose was measured using the glucose oxidase method, and 
A1C was measured by high-performance liquid chromatogra-
phy (HPLC) using Variant II Turbo (Bio-Rad Laboratories, 
Hercules, CA, USA). Serum insulin and C-peptide levels were 
measured in duplicate by using an immunoradiometric assay 
(IRMA) method (Beckman Coulter, Fullerton, CA, USA). 
Samples for laboratory measurements were simultaneously 
collected during a standardized mixed-meal stimulation test.
Assessment of the β-cell functional status
Pancreatic β-cell function and insulin sensitivity were obtained 
by homeostasis model assessment (HOMA) using HOMA of 
pancreatic β-cell function (HOMA-β) calculated as basal in-
sulin (μIU/mL)×20/basal glucose (mmol/L)-3.5, and HOMA 
of insulin resistance (HOMA-IR) calculated as basal insulin 
(μIU/mL)×glucose (mmol/L)/22.5. Pancreatic β-cell secretary 
function or insulin reserve were also determined from a mixed-
meal stimulation test calculated by dividing the increase in in-
sulin level by the increase in glucose level over the same period 
(insulinogenic index; IGI=[insulin (90′)–insulin (0′)]/[glu-
cose (90′)–glucose (0′)]).
Statistical analyses
Data are given as means±standard deviation (SD) for normal-
ly distributed variables, and otherwise as medians (25th and 
75th percentile values). Mean values and median value were 
compared between diabetes and IFG patients using unpaired 
Student’s t-test and Mann-Whitney U-test as appropriate. Pear-
son’s correlation coefficient was used to determine the correla-
tion between continuous parameters. Multiple linear regres-
sion analyses were performed using postprandial TG as a de-
pendent factor. Several clinical and laboratory factors (e.g., 
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age, sex, WC, glucose AC, HDL-C, and HOMA-IR) were en-
tered as independent factors. An alpha level of 0.05 was ac-
cepted as significant for all statistical procedures. All statistical 
analyses were conducted using SPSS for Windows software 
version 18.0 (SPSS Inc., Chicago, IL, USA).
RESULTS 
Baseline characteristics of the patients 
A total of 639 patients satisfied the criteria, and were classified 
into 2 groups depending on their glucose status: group I, T2D 
patients (n=539); group II, IFG patients (n=100). The patients’ 
demographic and laboratory data are summarized in Table 1 
and Supplemental Table 1. The mean age was 57.5 years, and 
gender (364 men and 275 women) was relatively evenly dis-
tributed. The mean age was 57.5 years, and gender (364 men 
and 275 women) was relatively evenly distributed.
 There were no significant differences in age, sex and BMI in 
both groups. The level of fasting and postprandial glucose, and 
A1c were significantly higher in group I (141.21±47.2 mg/dL, 
255.30±78.14 mg/dL, 7.87±1.51 mg/dL, respectively) than in 
group II (104.22±14.90 mg/dL, 146.46±32.24 mg/dL, 6.25± 
0.98 mg/dL) (P<0.001 for all). Postprandial insulin, C-peptide 
and HOMA-β were statistically higher in group II (67.30 [10.12 
to 259.96] μIU/mL, 7.72±3.30 μg/L, 62.28 [9.47 to 654.00], re-
spectively) than group I (50.68 [2.77 to 350.00] μIU/mL, 6.83±
4.93 μg/L, 46.35 (-1,522 to 2,433), respectively) (P=0.015, P=
0.026, P<0.001). WC, waist/hip ratio (WHR) and HOMA-IR 
were significantly higher in group I (88.11±9.38 cm, 0.91± 
0.058, 2.95 [0.38 to 44.61], respectively) than in group II (85.75± 
10.08 cm, 0.89±0.057, 1.88 (0.25 to 9.37), respectively) (P=
0.030, P=0.001, P<0.001). However, fasting TG (126 [33 to 
2,010] vs. 125.5 [41 to 384]; group I vs. group II, P=0.432) and 
postprandial TG (156 [40 to 2,220] vs. 142 [37 to 388]; group I 
Table 1. Baseline characteristics of the study subjects
Characteristic All subjects (n=639) Group 1 (T2D) (n=539) Group 2 (IFG) (n=100) P value
Age, yr 57.57±11.15 57.7±11.2 56.59±10.77 NS
Sex (male), % 57 59 52 NS
BMI, kg/m2 25.52±3.66 25.22±3.75 25.58±3.64 NS
WC, cm 87.75±9.52 88.11±9.38 85.75±10.08 0.030 
WHR 0.91±0.058 0.91±0.058 0.89±0.057 0.001 
Glucose at 0 min, mg/dL 135.42±45.81 141.21±47.2 104.22±14.90 <0.001
Glucose at 90 min, mg/dL 238.39±82.91 255.30±78.14 146.46±32.24 <0.001
A1c, % 7.62±1.56 7.87±1.51 6.25±0.98 <0.001
C-peptide at 0 min, μg/L 2.55±3.55 2.61±3.81 2.22±1.48 NS
C-peptide at 90 min, μg/L 6.97±4.72 6.83±4.93 7.72±3.30 0.026
Insulin at 0 min, μIU/mLa 11.10 (1.00-81.76) 8.99 (1.27-81.76) 7.03 (1.00-43.60) 0.040
Insulin at 90 min, μIU/mLa 65.52 (2.77-350.00) 50.68 (2.77-350.00) 67.30 (10.12-259.96) 0.015
Cholesterol, mg/dL 177.59±63.44 175.74±65.85 188.60±45.38 0.029
TG at 0 min, mg/dLa 148.4 (33-2,010) 126.0 (33-2,010) 125.5 (41-384) NS
TG at 90 min, mg/dLa 175.3 (37-2,220) 156.0 (40-2,220) 142.0 (37-388) NS
HDL-C 63.60±34.14 64.26±34.7 59.70±30.57 NS
LDL-C 82.48±39.95 79.23±38.10 101.82±45.2 <0.001
HOMA-IRa 3.71 (0.00-44.61) 2.95 (0.38-44.61) 1.88 (0.25-9.37) <0.001
HOMA-βa 75.28 (-1,522-2,433) 46.35 (-1,522-2,433) 62.28 (9.47-654.00) <0.001
IGIa 15.78 (-640-1,251) 6.67 (-247-1,251) 22.98 (-640.80-475.65) <0.001
T2D, type 2 diabetes; IFG, impaired fasting glucose; NS, not significant; BMI, body mass index; WC, waist circumference; WHR, waist/hip ra-
tio; TG, triglyceride; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; HOMA-IR, homeostatic model 
assessment of insulin resistance; HOMA-β, homeostatic model assessment of pancreatic β-cell function; IGI, insulinogenic index.
aDifferences between the 2 groups were analyzed by Mann-Whitney U-test. Data were presented as the median and 25th and 75th percentile values.
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vs. group II, P=0.052) were not significantly different between 
the 2 groups.
Independent correlation between plasma TG levels (fasting 
and postprandial) and clinical and metabolic parameters
A very strong (at least 0.9) linear relationship was observed 
between fasting and postprandial TG in T2D and IFG groups 
(r=0.973, r=0.937, respectively, P<0.001 for both; Fig. 1). In 
group I, fasting TG and postprandial TG were statistically cor-
related with total cholesterol (r=0.309, r=0.305, respectively), 
fasting glucose (r=0.151, r=0.162), A1c (r=0.143, r=0.162), 
WC (r=0.138, r=0.123), and BMI (r=0.118, r=0.108). Only 
postprandial TG was correlated with postprandial glucose 
(r=0.114, P=0.009), HOMA-IR (r=0.091, P=0.037), and fast-
ing C-peptide (r=0.089, P=0.042).
 In group II, fasting TG and postprandial TG were statisti-
cally correlated with postprandial insulin (r=0.328, r=0.330, 
respectively), postprandial C-peptide (r=0.312, r=0.320), WC 
(r=0.303, r=0.246), BMI (r=0.275, r=0.246), total cholesterol 
(r=0.238, r=0.246), and HOMA-IR (r=0.226, r=0.228, Table 
2).
Multiple linear regression analysis (postprandial TG as a 
dependent variable)
Of the several clinical and laboratory variables, only age, sex, 
HOMA-IR, WC, fasting and postprandial TG, HDL, and A1c 
showed a multicollinearity referring to a situation in which 2 
or more explanatory variables were highly linearly related dur-
ing a multiple regression model. In multiple regression analy-
sis, the postprandial TG was entered as the dependent variable. 
Independent variables were age, sex, fasting TG, HOMA-IR, 
HDL-C, glucose AC and WC. As shown in Table 3 the variables 
independently associated with postprandial TG were fasting 
TG in both groups (β=0.957, P<0.001 in the T2D group and 
β=0.906, P<0.001 in the IFG group) and HOMA-IR in the 
T2D group (β=0.827, P=0.024). In this regard, fasting TG and 
HOMA-IR could be a predictable variable for postprandial TG 
in subjects with T2D.
DISCUSSION
The gold standard measurement for hypertriglyceridemia is 
the fasting TG. Although controversial, fasting TG is known 
to be an independent risk factor for CVD [5,12]. However, 15 
to 18 hours a day are spent in the postprandial state and post-
prandial TG significantly contributes to overall TG exposure. 
In this regard, the use of fasting TG as a predictor for CVD 
does not provide information on diurnal TG profiles and indi-
vidual metabolism [9]. Accordingly, postprandial or non-fast-
ing TG levels are increasingly used as a predictor for CVD [13].
 While traditional Korean meals are usually not high in fat, 
the Korean diet has become more westernized. The increase of 
postprandial TG is known as mainly influenced by diet com-
position [2,4,14]. Additionally, patient’s characteristics such as 
Fig. 1. Correlation between plasma fasting triglyceride (TG) levels and postprandial TG levels in subjects with type 2 diabetes 
(A) and impaired fasting glucose (B).
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the use of lipid-lowering agents [15], WC [16,17], glycemic 
status [18,19], menopausal status and age [9] also affect the 
non-fasting TG profiles. Based on previous reports, the authors 
of the present study questioned the metabolic associations and 
clinical implications of postprandial TG in Korean patients 
with IFG and T2D. To answer these questions, the results of a 
standardized mixed-meal stimulation test were retrospectively 
analyzed in order to first identify the close correlation between 
fasting and postprandial TG and second, the clinical and labo-
ratory relevance of postprandial TG. In the present analysis, 
the mixed-meal stimulation test (Ensure; total 500 kcal, 17.5 g 
fat, 68.5 g carbohydrate, and 17.5 g protein) allowed for stan-
dardization of the calories, fat contents, and the times for blood 
sampling (basal and 90 minutes after meal loading). In addi-
tion, the influential effects of glucose status and insulin secre-
tion or resistance on both fasting and non-fasting TG levels 
could be analyzed.
 The present study shows 3 main results. First, fasting and 
postprandial TG demonstrated a very strong (at least 0.9) lin-
ear relationship in all subjects regardless of glucose status. In 
addition, the TG increment after a mixed-meal load was not 
contrasting. The likely explanation for these results is the type 
of low calorie and fat content diet (500 kcal, 17.5 g fat liquid 
loading) and a 30-minute earlier check of peak TG level. Spe-
cifically, 2 to 4 hours after a high-fat diet loading was the nec-
essary time point for postprandial TG to reach the highest lev-
el [3,9,12-14,20]. Only 1 well-designed study that enrolled Ko-
rean young women showed postprandial TG reached the peak 
time at 120 minutes after a high-fat meal ingestion [3]. How-
ever, no increase in postprandial TG after eating a high carbo-
hydrate meal was found [3]. Second, although both fasting 
and postprandial TG showed a similar correlation with other 
demographic and laboratory parameters in subjects with IFG, 
Table 2. Pearson’s correlation coefficients between fasting and postprandial TG and metabolic parameters 
Variable
T2D (n=539) IFG (n=100)
Fasting TG Postprandial TG Fasting TG Postprandial TG
Age, yr - 0.124 (0.004) - 0.125 (0.004) NS NS
BMI, kg/m2 0.118 (0.006) 0.108 (0.013) 0.275 (0.007) 0.246 (0.016)
WC, cm 0.138 (0.002) 0.123 (0.005) 0.303 (0.004) 0.266 (0.011)
Fasting TG, mg/dL 0.973 (<0.001) 0.937 (<0.001)
Postprandial TG, mg/dL 0.973 (<0.001) 0.937 (<0.001)
Glucose at 0 min, mg/dL 0.151 (<0.001) 0.162 (<0.001) NS NS
Glucose at 90 min, mg/dL NS 0.114 (0.009) NS NS
A1c, % 0.143 (0.001) 0.162 (<0.001) NS NS
C-peptide at 0 min, μg/L NS 0.089 (0.042) 0.219 (0.029) 0.198 (0.051)
C-peptide at 90 min, μg/L NS NS 0.312 (0.002) 0.320 (0.001)
Insulin at 90 min, μIU/mL NS NS 0.328 (0.001) 0.330 (0.001)
Total cholesterol, mg/dL 0.309 (<0.001) 0.305 (<0.001) 0.238 (0.031) 0.246 (0.027)
HOMA-IR NS 0.091 (0.037) 0.226 (0.024) 0.228 (0.023)
The numbers in parentheses refer to P values.
TG, triglyceride; T2D, type 2 diabetes; IFG, impaired fasting glucose; NS, not significant; BMI, body mass index; WC, waist circumference; 
HOMA-IR, homeostatic model assessment of insulin resistance.
Table 3. Multiple linear regression analysis (postprandial TG 
as the dependent variable) 
Variable
T2D (n=539) IFG (n=100)
Beta P value Beta P value
Age, yr - 0.017 0.212 -0.017 0.714
WC, cm -0.008 0.572 -0.070 0.219
Fasting TG, mg/dL 0.957 <0.001 0.906 <0.001
Glucose at 0 min, mg/dL 0.018 0.214 0.021 0.435
HDL-C, mg/dL 0.014 0.297 0.021 0.342
HOMA-IR 0.827 0.024 0.065 0.248
TG, triglyceride; T2D, type 2 diabetes; IFG, impaired fasting glucose; 
WC, waist circumference; HDL-C, high density lipoprotein choles-
terol; HOMA-IR, homeostatic model assessment of insulin resis-
tance.
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only postprandial TG showed a significant correlation with 
glucose metabolic parameters such as postprandial glucose, 
HOMA-IR and fasting C-peptide in subjects with T2D. In 
both T2D and IFG groups, fasting and postprandial TG were 
statistically correlated with total cholesterol and central obesi-
ty parameters such as WC and BMI. Third, fasting TG and 
HOMA-IR could be predictable variables for postprandial TG 
in subjects with T2D. In subjects with impaired fasting glucose, 
only fasting TG level predicted the level of postprandial TG.
 Regarding the characteristics of enrolled subjects, patients 
with T2D showed the typical pathophysiologic features with 
increased insulin resistance (WC, WHR, and HOMA-IR) and 
decreased insulin secretory function (HOMA-β, insulin and 
C-peptide levels at 90 minutes) resulting in increased glucose 
and A1c values. However, levels of total cholesterol and LDL-
C were significantly lower in subjects with T2D than with IFG 
(Table 1). The likely explanation involves the 50% and 27% us-
age of lipid-lowering drugs in T2D and IFG subjects, respec-
tively, which may affect the lower levels of cholesterols.
 There are several limitations of the present study. First, the 
study is a retrospective cross-sectional study, and the measure-
ments were taken after a single liquid meal. Second, subjects 
were diabetic patients who are usually taking some type of 
drug which were not individually analyzed in the present study. 
However, the study protocol using the low-fat mixed-meal test 
and measuring postprandial TG at 90 minutes is appropriate 
to analyze the influential effects of glucose status and insulin 
secretion or resistance on both fasting and non-fasting TG lev-
els in Korean subjects who traditionally do not eat a high-fat 
diet. This is the first, well-designed and relatively large scale 
study on clinical implication of postprandial TG on Korean T2 
diabetics. Further studies are essential to investigate the post-
prandial TG in all drug-naïve pre-diabetic and diabetic patients. 
 In conclusion, postprandial TG was strongly correlated with 
fasting TG. In addition, the present study shows a low-fat meal 
may have largely similar dietary effects on fasting and post-
prandial TG in Koreans with T2D. Especially, insulin resis-
tance may be more associated with postprandial TG than fast-
ing TG in Korean diabetic patients on a low-fat diet.
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